Clinical Trial Update: Evaluation of Quality of Life (QoL) in Subjects With Highly Active Relapsing Multiple Sclerosis (MS) (CLARIFY MS) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating quality of life in subjects with highly active relapsing multiple sclerosis; study completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2023-09-14